Project on Government Oversight, March 19, 2021: The Project on Government Oversight’s new report about the Pfizer COVID Vaccine raises questions about why the FDA did not publicly disclose quality control concerns that were publicly raised in Europe. We ask: Is “adequate” quality control good enough?
Read More »Tag: Vaccine
The Differences Between the Vaccines Matter
The Atlantic, March 7, 2021: Public-health officials are enthusiastic about all 3 COVID-19 vaccines available in the U.S. For example, Virginia’s vaccine coordinator stated, “A hundred percent efficacy against deaths and hospitalizations? That’s all I need to hear.” But experts, including NCHR, point out that there were too few people with severe COVID in the vaccine studies to draw conclusions.
Read More »What you need to know about J&J’s newly authorized one-shot COVID-19 vaccine
ScienceNews: February 27, 2021. On February 27, the FDA authorized Johnson & Johnson’s COVID-19 vaccine for use in the U.S. The other two authorized vaccines are made by Pfizer and Moderna. None are FDA approved. All show effectiveness, but there are too few serious COVID-19 cases in any of the studies to conclude how well it prevents hospitalizations or deaths.
Read More »Testimony of Dr. Diana Zuckerman at the FDA Advisory Committee on Johnson & Johnson COVID Vaccine
February 26, 2021: The Johnson & Johnson vaccine seems to be effective, but not proven to be more effective for moderate or severe COVID than the Pfizer or Moderna vaccines. We asked FDA to stop the hype and require studies to continue.
Read More »A Closer Look at HPV
Megan Cole, Diana Zuckerman, PhD, Brandel France de Bravo, MPH, and Janet A. Phoenix, MD, MPH, Cindy Min, MPH, National Center for Health Research What is HPV? The human papillomavirus virus, also known as HPV, is the most common sexually transmitted infection in the U.S. and around the world. In fact, approximately 20 million Americans […]
Read More »